Given that both primary and secondary storage substrates were required to initiate NLRP3 inflammasome‐mediated IL‐1β secretion, it is likely that several other lysosomal storage diseases, accumulating similar substrates, will share a similar mechanism of neuroinflammatory activation. This evidence concerns the gene NLRP3 and lysosomal storage disease.